Figure 2

Results of microsatellite assay and immunohistochemical analyses (IHC) in the mutator/MSI-type and suppressor/p53-type human EGCs. The status of microsatellite sequences was determined as described in the text. Immunoreactivity of p53 and hMLH1 was graded from − to +++. According to these results, tumours were subclassified into the mutator/MSI-type, suppressor/p53-type, and unclassified type tumours.